메뉴 건너뛰기




Volumn 60, Issue 10, 2011, Pages 1357-1358

Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN DETEMIR; INSULIN GLARGINE; METFORMIN; SULFONYLUREA;

EID: 80052965382     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.03.011     Document Type: Editorial
Times cited : (17)

References (23)
  • 3
    • 77954986682 scopus 로고    scopus 로고
    • Risk of cancer following hospitalization for type 2 diabetes
    • K. Hemminki, X. Li, and J. Sundquist Risk of cancer following hospitalization for type 2 diabetes Oncologist 15 2010 548 555
    • (2010) Oncologist , vol.15 , pp. 548-555
    • Hemminki, K.1    Li, X.2    Sundquist, J.3
  • 4
    • 77953837143 scopus 로고    scopus 로고
    • Linking diabetes and cancer: A consensus on complexity
    • A. Renehan, U. Smith, and M.S. Kirkman Linking diabetes and cancer: a consensus on complexity Lancet 375 2010 2201 2202
    • (2010) Lancet , vol.375 , pp. 2201-2202
    • Renehan, A.1    Smith, U.2    Kirkman, M.S.3
  • 7
    • 34547127614 scopus 로고    scopus 로고
    • Diabetes mellitus and risk of breast cancer: A meta-analysis
    • DOI 10.1002/ijc.22717
    • S.C. Larsson, C.S. Mantzoros, and A. Wolk Diabetes mellitus and risk of breast cancer: a meta-analysis Int J Cancer 121 2007 856 862 (Pubitemid 47106217)
    • (2007) International Journal of Cancer , vol.121 , Issue.4 , pp. 856-862
    • Larsson, S.C.1    Mantzoros, C.S.2    Wolk, A.3
  • 8
    • 40349112854 scopus 로고    scopus 로고
    • Diabetes, metabolic syndrome, and breast cancer: A review of the current evidence
    • F. Xue, and K.B. Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am J Clin Nutr 86 2007 s823 s835
    • (2007) Am J Clin Nutr , vol.86
    • Xue, F.1    Michels, K.B.2
  • 9
    • 80052968453 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
    • D.M. Baur, J. Klotsche, and O.P. Hamnvik Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort Metabolism 60 2011 1363 1371
    • (2011) Metabolism , vol.60 , pp. 1363-1371
    • Baur, D.M.1    Klotsche, J.2    Hamnvik, O.P.3
  • 10
    • 77955665369 scopus 로고    scopus 로고
    • Diabetes and risk of incident cancer: A large population-based cohort study in Israel
    • G. Chodick, A.D. Heymann, and L. Rosenmann Diabetes and risk of incident cancer: a large population-based cohort study in Israel Cancer Causes Control 21 2010 879 887
    • (2010) Cancer Causes Control , vol.21 , pp. 879-887
    • Chodick, G.1    Heymann, A.D.2    Rosenmann, L.3
  • 11
    • 80052965511 scopus 로고    scopus 로고
    • Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli Health Maintenance Organization: A historical cohort study
    • A.E. Buchs, and B.G. Silverman Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli Health Maintenance Organization: a historical cohort study Metabolism 60 2011 1379 1385
    • (2011) Metabolism , vol.60 , pp. 1379-1385
    • Buchs, A.E.1    Silverman, B.G.2
  • 12
    • 0021398917 scopus 로고
    • Growth-stimulatory actions of insulin in vitro and in vivo
    • D.S. Straus Growth-stimulatory actions of insulin in vitro and in vivo Endocr Rev 5 1984 356 369
    • (1984) Endocr Rev , vol.5 , pp. 356-369
    • Straus, D.S.1
  • 13
    • 77951835127 scopus 로고    scopus 로고
    • Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: The Hong Kong diabetes registry
    • X. Yang, G.T. Ko, and W.Y. So Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry Diabetes 59 2010 1254 1260
    • (2010) Diabetes , vol.59 , pp. 1254-1260
    • Yang, X.1    Ko, G.T.2    So, W.Y.3
  • 14
    • 47349117519 scopus 로고    scopus 로고
    • Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
    • DOI 10.1080/13813450801954451, PII 791408005, Proceedings of the Workshop on Insulin and Cancer
    • P. Pisani Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies Arch Physiol Biochem 114 2008 63 70 (Pubitemid 351998745)
    • (2008) Archives of Physiology and Biochemistry , vol.114 , Issue.1 , pp. 63-70
    • Pisani, P.1
  • 15
    • 77955923866 scopus 로고    scopus 로고
    • Metformin: Taking away the candy for cancer?
    • M. Jalving, J.A. Gietema, and J.D. Lefrandt Metformin: taking away the candy for cancer? Eur J Cancer 46 2010 2369 2380
    • (2010) Eur J Cancer , vol.46 , pp. 2369-2380
    • Jalving, M.1    Gietema, J.A.2    Lefrandt, J.D.3
  • 17
    • 69549097703 scopus 로고    scopus 로고
    • New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes
    • G. Libby, L.A. Donnelly, and P.T. Donnan New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes Diabetes Care 32 2009 1620 1625
    • (2009) Diabetes Care , vol.32 , pp. 1620-1625
    • Libby, G.1    Donnelly, L.A.2    Donnan, P.T.3
  • 18
    • 68449094325 scopus 로고    scopus 로고
    • The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    • C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 2009 1766 1777
    • (2009) Diabetologia , vol.52 , pp. 1766-1777
    • Currie, C.J.1    Poole, C.D.2    Gale, E.A.3
  • 19
    • 75149179169 scopus 로고    scopus 로고
    • Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16
    • G.W. Landman, N. Kleefstra, and K.J. van Hateren Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16 Diabetes Care 33 2010 322 326
    • (2010) Diabetes Care , vol.33 , pp. 322-326
    • Landman, G.W.1    Kleefstra, N.2    Van Hateren, K.J.3
  • 20
    • 79951576682 scopus 로고    scopus 로고
    • Time-window bias in case-control studies: Statins and lung cancer
    • S. Suissa, S. Dell'aniello, and S. Vahey Time-window bias in case-control studies: statins and lung cancer Epidemiology 22 2011 228 231
    • (2011) Epidemiology , vol.22 , pp. 228-231
    • Suissa, S.1    Dell'Aniello, S.2    Vahey, S.3
  • 21
    • 77952098898 scopus 로고    scopus 로고
    • Diabetes therapy and cancer risk: Causal effects and other plausible explanations
    • S. Hernandez-Diaz, and H.O. Adami Diabetes therapy and cancer risk: causal effects and other plausible explanations Diabetologia 53 2010 802 808
    • (2010) Diabetologia , vol.53 , pp. 802-808
    • Hernandez-Diaz, S.1    Adami, H.O.2
  • 22
    • 68349148204 scopus 로고    scopus 로고
    • Insulin glargine and malignancy: An unwarranted alarm
    • S.J. Pocock, and L. Smeeth Insulin glargine and malignancy: an unwarranted alarm Lancet 374 2009 511 513
    • (2009) Lancet , vol.374 , pp. 511-513
    • Pocock, S.J.1    Smeeth, L.2
  • 23
    • 79952260576 scopus 로고    scopus 로고
    • Diabetes mellitus, fasting glucose, and risk of cause-specific death
    • The Emerging Risk Factors Collaboration
    • The Emerging Risk Factors Collaboration Diabetes mellitus, fasting glucose, and risk of cause-specific death N Engl J Med 364 2011 829 841
    • (2011) N Engl J Med , vol.364 , pp. 829-841


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.